Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Chronic liver disease (CLD) is associated with tissue-destructive fibrosis. Considering that common mechanisms drive fibrosis across etiologies, and that steatosis is an important cofactor for pathology, we performed RNA sequencing on liver biopsies of patients with different fibrosis stages, resulting from infection with hepatitis C virus (HCV) (with or without steatosis) or fatty liver disease. In combination with enhanced liver fibrosis score correlation analysis, we reveal a common set of genes associated with advanced fibrosis, as exemplified by those encoding the transcription factor ETS-homologous factor (EHF) and the extracellular matrix protein versican (VCAN). We identified 17 fibrosis-associated genes as candidate EHF targets and demonstrated that EHF regulates multiple fibrosis-associated genes, including VCAN, in hepatic stellate cells. Serum VCAN levels were also elevated in advanced fibrosis patients. Comparing biopsies from patients with HCV with or without steatosis, we identified a steatosis-enriched gene set associated with advanced fibrosis, validating follistatin-like protein 1 (FSTL1) as an exemplar of this profile. In patients with advanced fibrosis, serum FSTL1 levels were elevated in those with steatosis (versus those without). Liver Fstl1 mRNA levels were also elevated in murine CLD models. We thus reveal a common gene signature for CLD-associated liver fibrosis and potential biomarkers and/or targets for steatosis-associated liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A survey of best practices for RNA-seq data analysis
Conesa, A., Madrigal, P., Tarazona, S., Gomez-Cabrero, D., Cervera, A., McPherson, A., Szcześniak, M. W., Gaffney, D. J., Elo, L. L., Zhang, X., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-0881-8 · Cited by 2,794 · cited 1×
“Normalization was performed after filtering the data, as has been previously recommended for analysis of RNA-sequencing data (94).”
MethodCarcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Kim, S., Takahashi, H., Lin, W.-W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.-L., & Karin, M. (2009) · Nature · doi:10.1038/nature07623 · Cited by 1,100 · cited 2×
“Our attention was drawn to one of these, VCAN , which encodes an ECM protein recently implicated in the activation of HSCs (37) and that has also been linked to inflammation and cancer metastasis (38).”
BackgroundThe ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086 · cited 1×
“Although EHF has been reported to act as a transcriptional repressor (60), individual members of the ETS family can act as both transcriptional activators and repressors in different contexts (61, 62).”
BackgroundWree, A., Eguchi, A., McGeough, M. D., Pena, C. A., Johnson, C. D., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2014) · Hepatology · doi:10.1002/hep.26592 · Cited by 945
Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711 · cited 1×
“Although it is currently unclear which receptors are required for FSTL1-mediated inflammatory responses, recent studies have implicated both the NLRP3 inflammasome and IL-17 signaling in down-stream responses, both of which are strongly implicated in liver fibrosis and adipogenesis (48, 80–85).”
BackgroundGalang, C. K., Muller, W. J., Foos, G., Oshima, R. G., & Hauser, C. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311887200 · Cited by 132 · cited 1×
“01 Fibrosis stageA 0 6 (23) NA NA 3 (10) NA NA 3 (22) NA NA 1 5 (19) NA 5 (17) NA 5 (36) NA 2 5 (19) NA 8 (28) NA 2 (14) NA 3 NA 7 (27) NA 5 (17) NA 2 (14) 4 NA 3 (12) NA 8 (28) NA 2 (14) AData presented categorically as n (%) and analyzed using χ2 test.”
Lefebvre, P., Lalloyer, F., Baugé, E., Pawlak, M., Gheeraert, C., Dehondt, H., Vanhoutte, J., Woitrain, E., Hennuyer, N., Mazuy, C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92264 · Cited by 117 · cited 1×
“01 Fibrosis stageA 0 6 (23) NA NA 3 (10) NA NA 3 (22) NA NA 1 5 (19) NA 5 (17) NA 5 (36) NA 2 5 (19) NA 8 (28) NA 2 (14) NA 3 NA 7 (27) NA 5 (17) NA 2 (14) 4 NA 3 (12) NA 8 (28) NA 2 (14) AData presented categorically as n (%) and analyzed using χ2 test.”
Cited by
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
“Informaticsbased approaches are increasingly utilized to uncover molecular signatures from tissue and stellate cells that can identify targets and predict outcomes (Hicks et al., 2017; Marcher et al., 2019; Ramnath et al., 2018; Wooden et al., 2017).”
BackgroundThe Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
Rao, J., Wang, H., Ni, M., Wang, Z., Wang, Z., Wei, S., Liu, M., Wang, P., Qiu, J., Zhang, L., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325150 · Cited by 241
“41 42 Our data showed that FSTL1 expression is significantly increased in macrophages of human or mouse liver fibrotic tissues.”
Prediction of drug efficacy from transcriptional profiles with deep learning
Zhu, J., Wang, J., Wang, X., Gao, M., Guo, B., Gao, M., Liu, J., Yu, Y., Wang, L., Kong, W., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00946-z · Cited by 193
Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis
Yang, Y. M., Noureddin, M., Liu, C., Ohashi, K., Kim, S. Y., Ramnath, D., Powell, E. E., Sweet, M. J., Roh, Y. S., Hsin, I.-F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat9284 · Cited by 166
Self-citation
Metadata
- Authors
- Ramnath, D., Irvine, K. M., Lukowski, S. W., Horsfall, L. U., Loh, Z., Clouston, A. D., Patel, P. J., Fagan, K. J., Iyer, A., Lampe, G., Stow, J. L., Schroder, K., Fairlie, D. P., Powell, J. E., Powell, E. E., & Sweet, M. J.
- Venue
- JCI Insight
- Published
- 2018-07-25
- Volume
- 3
- Issue
- 14
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W2883203008
- Cited by
- 47
- References
- 7
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.